human rhinovirus protease 3C inhibitors (Angelini Ricerche SpA)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Namehuman rhinovirus protease 3C inhibitors (Angelini Ricerche SpA)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPicornain 3C protease inhibitors
TargetsPicornain 3C protease
Therapy Area/IndicationsRhinovirus infection
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryItaly
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAngelini Pharma SPA
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAngelini Pharma SPA
Active IndicationsN/A
Inactive IndicationsRhinovirus infection

Other Information

ATC CodeN/A
Related LinksN/A